Emissary Wealth’s Aurinia Pharmaceuticals AUPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$255K Hold
15,757
– – 0.18% 60
2026
Q2
$267K Buy
+15,757
New +$252K 0.2% 58

Other funds holding AUPH

Emissary Wealth's AUPH Position: Q3 2026 in Review

Emissary Wealth held its Aurinia Pharmaceuticals (AUPH) position steady in Q3 2026 at 15,757 shares worth $255K. The position accounts for 0.18% of the portfolio, ranked #60.

Emissary Wealth first reported a position in AUPH in Q2 2026 and has held it in 2 quarters since. The position peaked at $267K in Q2 2026. 277 funds tracked by Wall St. Rank hold AUPH as of Q3 2026.

  • Emissary Wealth held 15,757 shares of Aurinia Pharmaceuticals worth $255K as of Q3 2026.
  • Emissary Wealth left its Aurinia Pharmaceuticals share count unchanged in Q3 2026.
  • Aurinia Pharmaceuticals made up 0.18% of Emissary Wealth's portfolio in Q3 2026, its #60 holding.
  • Emissary Wealth first reported a position in Aurinia Pharmaceuticals in Q2 2026 and has held it in 2 quarters since.
  • Emissary Wealth's Aurinia Pharmaceuticals position peaked at $267K in Q2 2026.
  • 277 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q3 2026.

Based on Emissary Wealth's 13F filing for Q3 2026, filed 9 Nov 2026.